FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2517622170> ?p ?o ?g. }

• W2517622170 abstract "A minor part of patients with subclavian or innominate artery occlusive disease (subclavian artery stenosis [SAS]) experience symptoms of vertebrobasilar insufficiency, upper extremity exertional ischemia (UEEI), or cardiac ischemia owing to subclavian-coronary steal (SCS) in some instances. The study aimed to assess the impact of percutaneous transluminal angioplasty (PTA) of symptomatic SAS on symptom resolution and to determine factors related with SAS recurrence.Symptom resolution and incidence of restenosis (RS) were evaluated for up to 15 years in patients who had undergone successful PTA of SAS.The study group comprised 232 consecutive subjects after successful PTA of SAS (61.9 ± 8.4 years old 53.4% men). The mean follow-up time was 101 ± 40 months (range, 5-188 months). One month after PTA, 85.4% of the study participants were free from dizziness, 94.4% from imbalance, 97.1% from visual disturbances, 97.8% from syncope, 98.7% from UEEI, and 100% from SCS. RS was found in 37 patients (15.9%) in long-term observation. UEEI, dizziness, imbalance, and SCS were significantly more frequent in patients with SAS recurrence, as compared with patients with patent artery (65.9% vs 3.1% [P < .001] 63.4% vs 19.4% [P < .001]; 26.8% vs 9.4% [P = .005]; and 100% vs 15.4% [P = .018], respectively). Smaller stent diameter (odds ratio [OR], 0.87; 95% confidence interval [CI], 0.79-0.96; P = .004), implantation of ≥2 stents for a lesion (OR, 1.15; 95% CI, 1.05-1.26; P = .003), concomitant stenosis in the carotid or vertebral artery (OR, 1.10; 95% CI, 1.01-1.21; P = .036), high-sensitivity C-reactive protein level (OR, 1.20; 95% CI, 1.09-1.31; P < .001), and high-density lipoprotein level (OR, 0.91; 95% CI, 0.82-0.98; P = .021) were associated independently with risk of RS, whereas recurrence of UEEI (relative risk, 1.71; 95% CI, 1.55-1.90; P < .001), dizziness (OR, 1.26; 95% CI, 1.14-1.39; P < .001), limb paresthesia (OR, 1.14; 95% CI, 1.04-1.25; P = .005), and angina in subjects after coronary artery bypass grafting (OR, 1.11; 95% CI, 1.01-1.21; P = .024) were associated with RS/SAS progression after PTA.Angioplasty of SAS leads to symptom resolution in most patients. UEEI, dizziness, and angina recurrence are predictors of RS or SAS progression; high-sensitivity C-reactive protein, smaller stent diameter, and number of implanted stents predict RS." @default.
• W2517622170 created "2016-09-16" @default.
• W2517622170 creator A5004542626 @default.
• W2517622170 creator A5007515072 @default.
• W2517622170 creator A5007999411 @default.
• W2517622170 creator A5015171057 @default.
• W2517622170 creator A5024836502 @default.
• W2517622170 creator A5044565425 @default.
• W2517622170 creator A5061200973 @default.
• W2517622170 creator A5061680094 @default.
• W2517622170 date "2016-09-01" @default.
• W2517622170 modified "2023-09-29" @default.
• W2517622170 title "Resolution of ischemic symptoms after percutaneous angioplasty for a symptomatic subclavian artery stenosis" @default.
• W2517622170 cites W1595771917 @default.
• W2517622170 cites W1987732159 @default.
• W2517622170 cites W1994797084 @default.
• W2517622170 cites W1996586432 @default.
• W2517622170 cites W2003045968 @default.
• W2517622170 cites W2018126928 @default.
• W2517622170 cites W2027164766 @default.
• W2517622170 cites W2049902163 @default.
• W2517622170 cites W2055266928 @default.
• W2517622170 cites W2061835083 @default.
• W2517622170 cites W2075421261 @default.
• W2517622170 cites W2078470921 @default.
• W2517622170 cites W2086220603 @default.
• W2517622170 cites W2088160739 @default.
• W2517622170 cites W2103841682 @default.
• W2517622170 cites W2119374834 @default.
• W2517622170 cites W2123874951 @default.
• W2517622170 cites W2127832768 @default.
• W2517622170 cites W2153251261 @default.
• W2517622170 cites W2163638314 @default.
• W2517622170 cites W2164255617 @default.
• W2517622170 cites W2168051579 @default.
• W2517622170 cites W2168554257 @default.
• W2517622170 cites W3188911799 @default.
• W2517622170 doi "https://doi.org/10.1016/j.jvs.2016.04.031" @default.
• W2517622170 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27565589" @default.
• W2517622170 hasPublicationYear "2016" @default.
• W2517622170 type Work @default.
• W2517622170 sameAs 2517622170 @default.
• W2517622170 citedByCount "7" @default.
• W2517622170 countsByYear W25176221702017 @default.
• W2517622170 countsByYear W25176221702018 @default.
• W2517622170 countsByYear W25176221702021 @default.
• W2517622170 countsByYear W25176221702022 @default.
• W2517622170 crossrefType "journal-article" @default.
• W2517622170 hasAuthorship W2517622170A5004542626 @default.
• W2517622170 hasAuthorship W2517622170A5007515072 @default.
• W2517622170 hasAuthorship W2517622170A5007999411 @default.
• W2517622170 hasAuthorship W2517622170A5015171057 @default.
• W2517622170 hasAuthorship W2517622170A5024836502 @default.
• W2517622170 hasAuthorship W2517622170A5044565425 @default.
• W2517622170 hasAuthorship W2517622170A5061200973 @default.
• W2517622170 hasAuthorship W2517622170A5061680094 @default.
• W2517622170 hasBestOaLocation W25176221701 @default.
• W2517622170 hasConcept C126322002 @default.
• W2517622170 hasConcept C141071460 @default.
• W2517622170 hasConcept C156957248 @default.
• W2517622170 hasConcept C164705383 @default.
• W2517622170 hasConcept C2776300738 @default.
• W2517622170 hasConcept C2777776602 @default.
• W2517622170 hasConcept C2778283817 @default.
• W2517622170 hasConcept C2778583881 @default.
• W2517622170 hasConcept C2780007028 @default.
• W2517622170 hasConcept C2780326628 @default.
• W2517622170 hasConcept C2780405337 @default.
• W2517622170 hasConcept C2780813298 @default.
• W2517622170 hasConcept C2781072225 @default.
• W2517622170 hasConcept C71924100 @default.
• W2517622170 hasConceptScore W2517622170C126322002 @default.
• W2517622170 hasConceptScore W2517622170C141071460 @default.
• W2517622170 hasConceptScore W2517622170C156957248 @default.
• W2517622170 hasConceptScore W2517622170C164705383 @default.
• W2517622170 hasConceptScore W2517622170C2776300738 @default.
• W2517622170 hasConceptScore W2517622170C2777776602 @default.
• W2517622170 hasConceptScore W2517622170C2778283817 @default.
• W2517622170 hasConceptScore W2517622170C2778583881 @default.
• W2517622170 hasConceptScore W2517622170C2780007028 @default.
• W2517622170 hasConceptScore W2517622170C2780326628 @default.
• W2517622170 hasConceptScore W2517622170C2780405337 @default.
• W2517622170 hasConceptScore W2517622170C2780813298 @default.
• W2517622170 hasConceptScore W2517622170C2781072225 @default.
• W2517622170 hasConceptScore W2517622170C71924100 @default.
• W2517622170 hasLocation W25176221701 @default.
• W2517622170 hasLocation W25176221702 @default.
• W2517622170 hasOpenAccess W2517622170 @default.
• W2517622170 hasPrimaryLocation W25176221701 @default.
• W2517622170 hasRelatedWork W190857592 @default.
• W2517622170 hasRelatedWork W1982045352 @default.
• W2517622170 hasRelatedWork W2016900092 @default.
• W2517622170 hasRelatedWork W2018126928 @default.
• W2517622170 hasRelatedWork W2023474392 @default.
• W2517622170 hasRelatedWork W2076542567 @default.
• W2517622170 hasRelatedWork W2118244653 @default.
• W2517622170 hasRelatedWork W2265750178 @default.
• W2517622170 hasRelatedWork W2266169315 @default.
• W2517622170 hasRelatedWork W2288057842 @default.
• W2517622170 hasRelatedWork W2377025196 @default.

• next